Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
524 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00479856 | Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer | terminated | Phase 2 | 9 | GlaxoSmithKlineINDUSTRY | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00400335 | Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride | completed | Phase 1 | 60 | GlaxoSmithKlineINDUSTRY | 1 | Jun 4, 2012 | clinicaltrials |
| NCT01205230 |
| VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK |
| completed |
| Phase 4 |
| 34 |
| GlaxoSmithKlineINDUSTRY |
| 1 |
| May 22, 2012 |
| clinicaltrials |
| NCT01221987 | Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer | completed | — | 40 | GlaxoSmithKlineINDUSTRY | 0 | Apr 30, 2012 | clinicaltrials |
| NCT00820924 | Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells | terminated | Phase 2 | 23 | GlaxoSmithKlineINDUSTRY | 2 | Mar 28, 2012 | clinicaltrials |
| NCT00698516 | Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer | completed | Phase 2 | 50 | GlaxoSmithKlineINDUSTRY | 1 | Mar 27, 2012 | clinicaltrials |
| NCT01445587 | A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma | withdrawn | Phase 2 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00561795 | Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors | completed | Phase 2 | 12 | GlaxoSmithKlineINDUSTRY | 2 | Mar 22, 2012 | clinicaltrials |
| NCT00558363 | ARTS - AVODART After Radical Therapy For Prostate Cancer Study(ARTS) | completed | Phase 2 | 294 | GlaxoSmithKlineINDUSTRY | 9 | Mar 21, 2012 | clinicaltrials |
| NCT00078572 | Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer | completed | Phase 3 | 408 | GlaxoSmithKlineINDUSTRY | 0 | Dec 13, 2010 | clinicaltrials |
| NCT00085813 | Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Oct 4, 2010 | clinicaltrials |
| NCT00097409 | Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 1 | Oct 4, 2010 | clinicaltrials |
| NCT01160185 | Meta-analysis of Efficacy of Topotecan | completed | — | 1 | GlaxoSmithKlineINDUSTRY | 0 | Jul 12, 2010 | clinicaltrials |
| NCT00169572 | Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | completed | Phase 2 | 492 | GlaxoSmithKlineINDUSTRY | 19 | May 10, 2010 | clinicaltrials |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 5 | Apr 6, 2010 | clinicaltrials |
| NCT00858000 | Analysis of Expression of Specific Markers in Hepatocellular Carcinoma | completed | — | 30 | GlaxoSmithKlineINDUSTRY | 1 | Dec 24, 2009 | clinicaltrials |
| NCT00259987 | Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus | completed | Phase 2 | 24 | GlaxoSmithKlineINDUSTRY | 3 | May 18, 2009 | clinicaltrials |
| NCT00085878 | Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors | completed | Phase 1 | 25 | GlaxoSmithKlineINDUSTRY | 1 | Oct 16, 2008 | clinicaltrials |
| NCT00119171 | Ispinesib In Combination With Capecitabine In Patients With Solid Tumors | completed | Phase 1 | 30 | GlaxoSmithKlineINDUSTRY | 1 | Oct 16, 2008 | clinicaltrials |
| NCT00136513 | SB-743921 In Patients With Solid Tumors | completed | Phase 1 | 30 | GlaxoSmithKlineINDUSTRY | 1 | Oct 16, 2008 | clinicaltrials |
| NCT00169520 | SB-715992 In Combination With Docetaxel In Patients With Solid Tumors | completed | Phase 1 | 30 | GlaxoSmithKlineINDUSTRY | 1 | Oct 16, 2008 | clinicaltrials |
| NCT00085904 | Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas | completed | Phase 1 | 12 | GlaxoSmithKlineINDUSTRY | 1 | Oct 13, 2008 | clinicaltrials |
| NCT00572000 | Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule(HPV-022 PRI) | unknown | N/A | 222 | National Institute for Control of Vaccine and BiologicalsOTHER_GOV | 1 | Dec 12, 2007 | clinicaltrials |
| NCT00062894 | Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab | completed | Phase 1 / Phase 2 | 12 | GlaxoSmithKlineINDUSTRY | 1 | Sep 17, 2007 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials